Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Autor: Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink

Publikováno v: Rheumatic & Musculoskeletal Diseases Open, 8, 1
RMD open, 8(1):002035. BMJ Publishing Group
Rheumatic & Musculoskeletal Diseases Open, 8
RMD Open, 8(1):002035. BMJ Publishing Group
Boekel, L, Hooijberg, F, Vogelzang, E H, Besten, Y R, Leeuw, M, Atiqi, S, van Vollenhoven, R F, Wijbrandts, C A, Gerritsen, M, Krieckaert, C, Dijkshoorn, B, Bakhlakh, S, Crooijmans, J J, Voskuyl, A, van der Horst-Bruinsma, I E, Lems, W, Kuijpers, T W, van Ham, S M, Wieske, L, Eftimov, F, Kummer, L Y, van Dam, P K, Stalman, E W, Steenhuis, M, Keijzer, S, Cristianawati, O, Keijser, J, Loeff, F C, Tas, S W, Nurmohamed, M T, Boers, M, Rispens, T & Wolbink, G 2022, ' Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases : data from a prospective cohort study ', RMD Open, vol. 8, no. 1, 002035 . https://doi.org/10.1136/rmdopen-2021-002035

BackgroundResearch on the disease severity of COVID-19 in patients with rheumatic immune-mediated inflammatory diseases (IMIDs) has been inconclusive, and long-term prospective data on the development of SARS-CoV-2 antibodies in these patients are la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1435379ab158ca7d4c0cf06c2e660c43